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The International Continence Society defines stress urinary incontinence
(SUI) as the complaint of involuntary leakage of urine on effort or exertion,
or on sneezing or coughing. SUI affects 1 in 3 women.
• This occurs in response to sudden increases in intra-abdominal pressure
(IAP) during exertional activities in the presence of weak pelvic floor
muscles (PFM) which fail to provide enough resistance to dissipate IAP.
• Pelvic floor muscle (PFM) training is considered a first line treatment for
SUI. Since these muscles are out of sight and do not move a joint it is
difficult for women to contract them appropriately, consequently many
recruit other muscles or perform a bearing down maneuver which can
exacerbate their SUI or potentially lead to pelvic organ prolapse.
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Tranabdominal ultrasound image shows cranial bladder base displacement (1.04cm) by INNOVO®
elicited pelvic floor contraction in standing at an intensity of 60mA.

This preliminary study describes the effects of INNOVO® shorts, a recent
FDA cleared wearable neuromuscular electrical stimulation garment on
pelvic floor function in women with and without SUI.

Pelvic floor training is a first line intervention for many pelvic floor
disorders. Ability to perform contractions is essential to successful
outcomes but are challenging for many. These individuals may use
vaginal/anal probes with electrical stimulation (ES) to facilitate
contractions. However, the evidence regarding this method reports
contractions occurring in only 11-16% in addition to limited
compliance due to large current densities, pain and or vaginal/anal
bleeding. INNOVO® has extremely low current density and elicits
comfortable contractions. Efficacy is high in SUI with 93% improved in
4 weeks and 87.2% dry or categorized as mild. Given the quality of the
elicited contractions noted on US and reported outcomes, INNOVO®
offers a safe and effective non-invasive home treatment option for
those with SUI and potentially other pelvic floor disorders such as
fecal incontinence and pelvic organ prolapse.

METHODS
Thirty females (10 SUI) provided informed consent. Each donned the
INNOVO® shorts in standing with intensity modified to elicit PFM
contractions visible on ultrasound imaging (US). Transabdominal (TAUS)
and transperineal (TPUS) US cineloops were acquired using a curvilinear
transducer. Appropriate contractions were defined as cranial (TAUS) and
cranioventral (TPUS) displacement of the bladder base and neck
respectively.
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Figure 2.

Midsagittal plane transperineal ultrasound at rest (A) and during INNOVO elicited pelvic floor muscle
contraction in standing (B): anorectal angle (ARA, dotted line), the levator plate angle (LP, full line),
pubic symphysis (PS), and the horizontal reference line. During a PFM contraction the ARA becomes
more acute and moves cranially and the LP angle increases.
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RESULTS & DISCUSSION
Pelvic floor contractions were observed for all participants. Mean
displacement of the bladder base via TAUS was 0.96cm (SD 0.53cm). TPUS
confirmed INNOVO® elicited pelvic floor contractions and changed the
anorectal angle with concomitant anterior urethral displacement towards
the pubic symphysis.
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Figure 3.

TPUS image using shear wave elastography of the right levator ani (Q-Box trace – dashed lines) in standing at rest
(A) and during an INNOVO (B) elicited PFM contraction in standing. The mean shear modulus increased by 114%
from rest to INNOVO elicited pelvic floor muscle contractions for the right levator ani (13.3 vs 28.5 kPa), thus
indicating a mechanical change in the muscle elicited by INNOVO. An increase in shear modulus is associated with
increased torque and contraction intensity of muscle.
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